The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Study reveals that sleep traits predict over 15% of body characteristics across 15 physiological systems, with visceral fat, ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

In a Q&A, Brian Wojeck, MD, MPH, discusses how weight and sleep impact each other and how discovering connections between diabetes, obesity, and sleep disorders can lead to better treatment.

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...